{
    "organizations": [],
    "uuid": "6765f47a09886240bc0acbf51efb61cdf4eeaf33",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-polus-biopharm-to-issue-26th-serie/brief-polus-biopharm-to-issue-26th-series-convertible-bonds-worth-20-bln-won-idUSL4N1QG1R4",
    "ord_in_thread": 0,
    "title": "BRIEF-Polus BioPharm to issue 26th series convertible bonds worth 20 bln won",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Polus BioPharm Inc :\n* Says it will issue 26th series unregistered and unsecured private convertible bonds, to raise 20 billion won in proceeds for operations\n* Maturity date is March 9, 2023, coupon rate is 4 percent and yield to maturity is 4 percent for the bonds\n* Conversion price is 15,759 won/share and conversion ratio is 100 percent\nSource text in Korean: goo.gl/vn7PQJ\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-26T11:21:00.000+02:00",
    "crawled": "2018-02-26T16:52:19.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "polus",
        "biopharm",
        "inc",
        "say",
        "issue",
        "26th",
        "series",
        "unregistered",
        "unsecured",
        "private",
        "convertible",
        "bond",
        "raise",
        "billion",
        "proceeds",
        "operation",
        "maturity",
        "date",
        "march",
        "coupon",
        "rate",
        "percent",
        "yield",
        "maturity",
        "percent",
        "bond",
        "conversion",
        "price",
        "conversion",
        "ratio",
        "percent",
        "source",
        "text",
        "korean",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}